Randomized clinical trial: a controlled pilot trial of the 5- HT4 receptor agonist revexepride in patients with symptoms suggestive of gastroparesis. - Tack, J.; Rotondo, A.; Meulemans, A.; Thielemans, L.; Cools, M. (Neurogastroenterology & Motility, 2016)